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and progestogen including the expected
incidence of breast and pituitary tumours.
Epidemiological studies currently in progress
have not revealed any relationship between
the use of oral chemical contraceptives and
the incidence of breast tumours in women.
It is concluded there is no evidence avail-
able at present to implicate any particular
exogenous chemical in the aetiology ofhuman
breast cancer. Careful monitoring should be
maintained in women using oral contra-
ceptives. Further investigation is required
of the possible combined effects of small
amounts of different chemical carcinogens.
A SURGEON'S VIEW OF ENVIRON-
MENTAL FACTORS IN HUMAN
MAMMARY CANCER. J. MAXWELL
ANDERSON. Royal Infirmary, Glasgow.
The importance of environmental agents
in mammary cancer lies in the valuable con-
tribution that clarification of the aetiology of
diseases in general can bring to the welfare of
humanity. Thefamilial occurrence ofhuman
mammary cancer presents undoubtedly valid
evidence for the weak operation of a heredi-
tary factor; nevertheless the possible incor-
poration of virus material into the genome
requires elucidation.
Causes of disease may be immediate or
contributory. No cause of mammary cancer
can be said to be immediate in that its unique
operation brings about the disease, but there
are a number of possible contributory causes
which bring the host and the target organ
under the influence of immediate causes,
whatever they may be.
Environmental contributory causes of
disease may be of a negative sort-nutri-
tional defect or metabolic abnormality-or of
a positive sort-living organisms or agents
arising outside or within the body. These
exogenous or endogenous agents dominate
the aetiology of most human cancers and a
heterogeneous assortment of factors-
chemical compounds, radiant energy, para-
sites, viruses, hormones and endogenous
metabolites-have been named. How this
diverse group of agents can be co-ordinated
within a single scheme of pathogenesis is the
most significant problem that confronts
cancer research today because it will lead to
prevention, efficient surveillance of those at
risk and earlier treatment of those escaping
preventive measures. Although the possible
effects of most of these agents have been
observed in human cancers, most of our
knowledge has been acquired through animal
studies. Of course, these fruitful investiga-
tions can only be applied to human pathology
with the greatest caution. By the use of
experiments emphasizing single variable
factors at one time we now recognize that a
multiplicity of agents can induce cancers in
animals, though many must operate at a
quite unnatural strength. What is needed
now to derive the maximum benefit from
these studies is a closer analysis of similar
situations under the controlled conditions of
large-scale collaborative studies. Unless
some important carcinogenic agents have
hitherto escaped recognition, the causes of
most mammary cancers must be sought
among endogenous chemical substances or
extrinsic factors operating directly through
the intermediation of endogenous carcino-
genic metabolites, hormones or viruses.
More precise information about the role of
oestrogen is required. Some polycyclic
hydrocarbons which induce mammary cancer
in mice have oestrogen-like effects and it is
well known that women who have not been
exposed to the high oestrogen levels of
pregnancy have a lower incidence of mam-
mary cancer than parous women. Also,
women who develop mammary cancer have
an abnormally long menstrual life with more
menstrual cycles than are found in matched
controls. Correlations of this aspect of
female physiology with the reported high
incidence of mammary cancer in males with
hyperoestrogenism might be sought, and it
seems unwise to prescribe oestrogens for
women known to belong to groups predis-
posedtothedevelopmentofmammary cancer.
Knowledge of the inter-relationships of
genetic susceptibility and hormonal stimula-
tion with a viral activity in mammary cancer
of mice requires to be applied to human
studies. The practical issues that might
emerge from the establishment of a virus as
an important cause of human mammary
cancer are (1) the development of specific
treatments by anti-viral chemotherapy,
stimulation of interferon production or
immunotherapy, (2) sub-clinical detection by
immunological or ultrastructural methods
and (3) prevention of infection by or trans-
mission of the virus.